TELMISARTAN/AMLO 80/5 telmisartan/amlodipine (as besilate) 80/5 mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

telmisartan/amlo 80/5 telmisartan/amlodipine (as besilate) 80/5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.935 mg; telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; povidone; magnesium stearate; citric acid; mannitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

TELMISARTAN AND AMLODIPINE tablet Estats Units - anglès - NLM (National Library of Medicine)

telmisartan and amlodipine tablet

alembic pharmaceuticals limited - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - telmisartan 40 mg - telmisartan and amlodipine tablets   are indicated for the treatment of hypertension, alone or with other antihypertensive agents to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including angiotensin ii receptor blockers and dihydropyridine calcium channel blockers. there are no controlled trials demonstrating risk reduction with telmisartan and amlodipine tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high b

TELMISARTAN AND AMLODIPINE tablet Estats Units - anglès - NLM (National Library of Medicine)

telmisartan and amlodipine tablet

avkare - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - telmisartan 40 mg - telmisartan and amlodipine tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including angiotensin ii receptor blockers and dihydropyridine calcium channel blockers. there are no controlled trials demonstrating risk reduction with telmisartan and amlodipine tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high bloo

TELMISARTAN SANDOZ telmisartan 40mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

telmisartan sandoz telmisartan 40mg tablet blister pack

sandoz pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; lactose; magnesium stearate; povidone; lactose monohydrate; crospovidone - telmisartan sandoz is indicated for treatment of hypertension, prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

TELMISARTAN SANDOZ telmisartan 80mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

telmisartan sandoz telmisartan 80mg tablet blister pack

sandoz pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: meglumine; magnesium stearate; lactose; sodium hydroxide; povidone; lactose monohydrate; crospovidone - telmisartan sandoz is indicated for treatment of hypertension, prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

PRITOR/AMLODIPINE 80 mg/10 mg telmisartan 80 mg/amlodipine (as besilate) 10 mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pritor/amlodipine 80 mg/10 mg telmisartan 80 mg/amlodipine (as besilate) 10 mg tablet blister pack

boehringer ingelheim pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: povidone; microcrystalline cellulose; maize starch; pregelatinised maize starch; sodium hydroxide; magnesium stearate; colloidal anhydrous silica; meglumine; sorbitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

PRITOR/AMLODIPINE 80 mg/5 mg telmisartan 80 mg/amlodipine (as besilate) 5 mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pritor/amlodipine 80 mg/5 mg telmisartan 80 mg/amlodipine (as besilate) 5 mg tablet blister pack

boehringer ingelheim pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; meglumine; magnesium stearate; maize starch; colloidal anhydrous silica; sodium hydroxide; povidone; sorbitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

PRITOR/AMLODIPINE 40 mg/10 mg telmisartan 40 mg/amlodipine (as besilate) 10 mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pritor/amlodipine 40 mg/10 mg telmisartan 40 mg/amlodipine (as besilate) 10 mg tablet blister pack

boehringer ingelheim pty ltd - telmisartan, quantity: 40 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, multilayer - excipient ingredients: colloidal anhydrous silica; sodium hydroxide; sorbitol; magnesium stearate; pregelatinised maize starch; povidone; microcrystalline cellulose; maize starch; meglumine; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

PRITOR/AMLODIPINE 40 mg/5 mg telmisartan 40 mg/amlodipine (as besilate) 5 mg tablet blister pack Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pritor/amlodipine 40 mg/5 mg telmisartan 40 mg/amlodipine (as besilate) 5 mg tablet blister pack

boehringer ingelheim pty ltd - telmisartan, quantity: 40 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, multilayer - excipient ingredients: magnesium stearate; meglumine; sorbitol; sodium hydroxide; microcrystalline cellulose; povidone; colloidal anhydrous silica; maize starch; pregelatinised maize starch; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)

APO-Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.